
Sign up to save your podcasts
Or


Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
By The Lancet NeurologyTobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

43,580 Listeners

293 Listeners

517 Listeners

50 Listeners

112,238 Listeners

93 Listeners

513 Listeners

190 Listeners

61 Listeners

83 Listeners

0 Listeners